FFCP PHASE1:Hg19::chr13:100927424..100927435,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:100927424..100927435,+ | |||
|description=CAGE_peak_at_chr13:100927424..100927435,+ | |||
|id=chr13:100927424..100927435,+ | |||
|ontology_enrichment_celltype=CL:0002127!3.41e-11!1;CL:0000914!3.41e-11!1;CL:0000911!3.41e-11!1;CL:0000814!3.41e-11!1;CL:0002042!3.41e-11!1;CL:0002039!3.41e-11!1;CL:0002040!3.41e-11!1;CL:0002041!3.41e-11!1;CL:0000763!2.30e-10!112;CL:0000049!2.30e-10!112;CL:0002032!1.03e-07!165;CL:0000837!1.03e-07!165;CL:0000037!2.59e-07!172;CL:0000566!2.59e-07!172;CL:0000988!8.50e-07!182 | |||
|ontology_enrichment_celltype_v019=CL:0002127;4.61e-26;1!CL:0000911;4.61e-26;1!CL:0000814;4.61e-26;1 | |||
|ontology_enrichment_celltype_v019_2=CL:0002127,4.61e-26,1;CL:0000914,4.61e-26,1;CL:0000911,4.61e-26,1;CL:0000814,4.61e-26,1;CL:0002042,4.61e-26,1;CL:0002039,4.61e-26,1;CL:0002040,4.61e-26,1;CL:0002041,4.61e-26,1;CL:0000893,9.40e-14,2;CL:0002489,9.40e-14,2;CL:0000809,9.40e-14,2;CL:0000808,9.40e-14,2;CL:0000894,9.40e-14,2;CL:0000806,9.40e-14,2;CL:0000807,9.40e-14,2;CL:0000805,9.40e-14,2;CL:0002425,9.40e-14,2;CL:0000763,3.72e-11,108;CL:0000049,3.72e-11,108;CL:0002032,9.03e-10,161;CL:0000837,9.03e-10,161;CL:0000037,2.31e-09,168;CL:0000988,6.97e-09,177 | |||
|ontology_enrichment_development_v019=CL:0002425;9.40e-14;2 | |||
|ontology_enrichment_disease=DOID:8692!1.07e-42!31;DOID:1240!1.37e-39!39;DOID:2531!8.16e-30!51;DOID:0060083!8.16e-30!51;DOID:9119!9.97e-11!1;DOID:225!1.61e-10!1;DOID:0050686!1.04e-09!137 | |||
|ontology_enrichment_disease_v019=DOID:1240;1.11e-39;39!DOID:8692;4.00e-38;31!DOID:2531;2.28e-22;51!DOID:0060083;2.28e-22;51 | |||
|ontology_enrichment_disease_v019_2=DOID:1240,2.12e-40,39;DOID:8692,6.14e-39,31;DOID:2531,5.96e-31,51;DOID:0060083,5.96e-31,51;DOID:0050686,1.76e-11,137 | |||
|ontology_enrichment_uberon=UBERON:0001154!1.10e-10!1;UBERON:0001153!1.10e-10!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002370,1.59e-07,4;UBERON:0005058,1.59e-07,4;UBERON:0009113,1.59e-07,4;UBERON:0003295,1.59e-07,4;UBERON:0005562,1.59e-07,4 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.361439152384566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122834317311768,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.24170287987055,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.372158369359667,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.798317485731266,0,9.52531122257473,0,0,1.82587743226554,1.72347885350326,0,0.169291777801603,0,0,0,9.96165499791718,1.22896305723383,0.671028323677248,1.83534055883099,7.81552381608161,0,0,0,0.33307196799782,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.276283915531148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.784901281975124,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.982829546539238,0,0,0,0.106691729694141,0,0,0,0,0,0,0,0,0,0,0.212574920101683,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0717222053926763,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:100927424..100927435,+ | |||
}} |
Latest revision as of 14:12, 24 July 2015
Short description: | p@chr13:100927424..100927435, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr13:100927424..100927435, + |
Coexpression cluster: | NA |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
innate effector T cell | 4.61e-26 | 1 |
immature NK T cell | 4.61e-26 | 1 |
effector T cell | 4.61e-26 | 1 |
mature NK T cell | 4.61e-26 | 1 |
immature NK T cell stage IV | 4.61e-26 | 1 |
immature NK T cell stage I | 4.61e-26 | 1 |
immature NK T cell stage II | 4.61e-26 | 1 |
immature NK T cell stage III | 4.61e-26 | 1 |
thymocyte | 9.40e-14 | 2 |
double negative thymocyte | 9.40e-14 | 2 |
double-positive, alpha-beta thymocyte | 9.40e-14 | 2 |
DN4 thymocyte | 9.40e-14 | 2 |
DN1 thymic pro-T cell | 9.40e-14 | 2 |
DN2 thymocyte | 9.40e-14 | 2 |
DN3 thymocyte | 9.40e-14 | 2 |
immature single positive thymocyte | 9.40e-14 | 2 |
early T lineage precursor | 9.40e-14 | 2 |
myeloid cell | 3.72e-11 | 108 |
common myeloid progenitor | 3.72e-11 | 108 |
hematopoietic oligopotent progenitor cell | 9.03e-10 | 161 |
hematopoietic multipotent progenitor cell | 9.03e-10 | 161 |
hematopoietic stem cell | 2.31e-09 | 168 |
hematopoietic cell | 6.97e-09 | 177 |
Ontology term | p-value | n |
---|---|---|
thymus | 1.59e-07 | 4 |
hemolymphoid system gland | 1.59e-07 | 4 |
thymic region | 1.59e-07 | 4 |
pharyngeal gland | 1.59e-07 | 4 |
thymus primordium | 1.59e-07 | 4 |
Ontology term | p-value | n |
---|---|---|
leukemia | 2.12e-40 | 39 |
myeloid leukemia | 6.14e-39 | 31 |
hematologic cancer | 5.96e-31 | 51 |
immune system cancer | 5.96e-31 | 51 |
organ system cancer | 1.76e-11 | 137 |